Pharmaceutical Drug Targets and Diseases
From Proteopedia
| Line 1: | Line 1: | ||
[[Image: Nexium.jpg|300px|right|thumb| AstraZeneca’s Nexium]] | [[Image: Nexium.jpg|300px|right|thumb| AstraZeneca’s Nexium]] | ||
| - | <big>The | + | <big>The following is a list of major phamerceutical compound targets, organized by disease. </big> |
{{TOC limit|limit=2}} | {{TOC limit|limit=2}} | ||
Revision as of 18:56, 15 September 2010
The following is a list of major phamerceutical compound targets, organized by disease.
Alzheimer’s Disease
Acetylcholinesterase
Amyloid Beta
Gamma-Secratase
Glutamate receptor (GluA2)
Anemia
Asthma and other Pulmonary Disease States
Beta-2-Andrenergic Receptor
Leukotriene Receptor
Autoimmune Diseases
Tumor Necrosis Factor Receptor
Blood Clots & Thrombic Events
Cancer
Epidermal Growth Factor & Epidermal Growth Factor Receptor
Human Epidermal Growth Factor Receptor 2
Phosphatidylinositol 3-Kinase
Tyrosine Kinase
Vascular Endothelial Growth Factor & Vascular Endothelial Growth Factor Receptor
Compromised Immune System
Granulocyte-macrophage colony-stimulating factor
Diabetes & Hypoglycemia
Peroxisome Proliferator-Activated Receptors
Digetsive Diseases
Erectile Dysfunction
cGMP-Specific Phosphodiesterase Type 5
HIV
Hypercholesterolemia (Elevated Cholesterol)
Hypertension & Congestive Heart Failure
Angiotensin-Converting Enzyme
Calcium Channel
Inflammation & Rheumatoid Arthritis
Schizophrenia, Bipolar Depression, Insomnia, and Other Anxiety Disorders
Dopamine Receptor
Andrenergic Receptor
Histamine Receptor
Opioid Receptor
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Alexander Berchansky, Eran Hodis, Thomas J. Stout, Wayne Decatur
